Clinical trial Recruiting at 1 site Interventional Ages 18 and up Men only

FELLAship program to improve heart and metabolic health in Black men

Official title: FELLAShip to Better Health

Run by University of Alabama at Birmingham · NCT07220213 · Data updated 2026-11-12

This program will try a 24-week, church-based combination of exercise and health education to see if it improves blood pressure, cholesterol, blood sugar, and weight for Black men age 18 and older in the Birmingham area.

More Obesity & Overweight trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexMen only
Enrollment90 (estimated)
SponsorUniversity of Alabama at Birmingham
Academic / other
Locations1 site (Birmingham, Alabama)
StatusRecruiting
StartedJanuary 1, 2026
Main results expectedJanuary 1, 2027
Study endsJanuary 1, 2027
Registry record updatedJanuary 22, 2026
Trial IDNCT07220213 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Self-identified Black men age 18 or older who live in the Birmingham metropolitan area, speak English, have less-than-ideal cardiovascular health (lower LE8 score), and have no medical restriction on physical activity.

Probably not a fit

Men with already ideal cardiovascular health, medical limits on physical activity, non-English speakers, or those living outside the Birmingham area likely will not benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

FELLAship is a faith-based intervention delivered at The Worship Center Christian Church that combines weekly 90-minute sessions—45 minutes of trainer-led physical activity and 45 minutes of health education—over 24 weeks. Participants are randomized to start the program immediately or after a waitlist delay to compare short-term health changes and implementation factors. The study collects cardiovascular health metrics (blood pressure, cholesterol, blood sugar), Life's Essential 8 components, and health behavior measures while also studying factors that affect adoption, delivery, and sustainability in a church setting. Findings will inform whether this model can be scaled to improve cardiovascular health among Black men.

Why it matters

Potential benefit: If successful, the program could lower blood pressure, cholesterol, and blood sugar while improving physical activity and weight, and create a sustainable church-based prevention model for Black men.

How similar studies have gone: Previous faith-based lifestyle programs targeting Black communities have shown mixed but generally encouraging improvements in activity, blood pressure, and weight, though implementation and long-term sustainability vary.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Self-identified Black men
* Age 18 or older
* LE8 (Life's Essential 8) score (threshold not specified, but implies "less than ideal" CVH)
* English speaking
* Resides in the Metropolitan Birmingham, Alabama area
* No physical activity restrictions imposed by a healthcare provider

Exclusion Criteria:

* Not identifying as Black and male
* Under age 18
* Non-English speakers
* Not living in the Birmingham, Alabama metro area
* Having a healthcare provider-imposed restriction on physical activity
* Ideal CVH (i.e., LE8 (Life's Essential 8) score above inclusion threshold)

Where it's running

  • The Worship Center Cristian Church
    Birmingham, Alabama, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.